Tristel Regulatory News (TSTL)

9 Aug 2006 12:00

Tristel PLC09 August 2006 Tristel plc Directors' Shareholdings Tristel plc ("Tristel"), the healthcare business which uses its proprietarychlorine dioxide chemistry for infection control in hospitals, in watertreatment and the food processing industry, announces that Paul Swinney, ChiefExecutive, has sold 174,017 ordinary shares to Peter Stephens, a non-executivedirector of Tristel, at a price of 48 pence per share. Paul Swinney's shareholding in Tristel after the sale is 2,544,969 ordinaryshares (10.68%) and Peter Stephens shareholding is 767,414 ordinary shares(3.22%). The share sale constitutes a repayment of a personal loan made to Paul Swinneyby Peter Stephens in August 2005. The loan was used by Paul Swinney to settlecertain tax and national insurance liabilities arising from his exercise of2,265,475 options upon Tristel's admission to AIM on 1st June 2005. For further information, please contact: Tristel plc Parkgreen Communications Ltd Paul Swinney, Chief Executive Paul McManusPaul Barnes, Finance Director Tel 020 7493 3716Tel: 01638 721 500 Mob: 07980 541 893http://www.tristel.com paul.mcmanus@parkgreenmedia.com This information is provided by RNS The company news service from the London Stock Exchange